Human Papillomavirus (HPV)

Locally made vaccines ‘could boost immunisation efforts’

Mexico and South Africa want to start producing their own vaccines to boost their immunisation programmes, the 67th World Health Assembly (WHA) in Switzerland has heard.
 
The countries need the WHO and other international agencies to help expand their local manufacturing capacity, a move they hope will lower the cost of vaccines and make their supply more reliable.
 
Undefined

Presentation: Strategies to supply high quality, affordable vaccines to emerging markets

At the last World Vaccine Congress Asia 2013, Xuefeng Yu of Tianjun Cansino Biotechnology gave the following presentation entitled: Strategies to supply high quality, affordable vaccines to emerging markets.
Some of the points covered in this presentation include:
 
  • Vaccine market status in developing countries
  • Current status to introduce new vaccine and improve quality of existing vaccines in developing countries
  • Challenges for developing country Manufactures (DCVMs)
Undefined

Vaccinating Children Beyond the ‘Cold Chain’: Extending the Heat Stability of Vaccines

Shipping and storing vaccines in a ‘cold chain’ in the tropical heat of many resource-limited countries – whereby the vaccine is kept at temperatures between 2°C to 8°C from the point of manufacture until reaching the recipient – is a tremendous challenge and a major cause of poor immunisation coverage rates.
Undefined

GAVI Alliance to present plans to expand impact of vaccines by 2020

As five African countries prepare to celebrate World Immunization Week (24-30 April) with the impending introduction of new vaccines, the GAVI Alliance is finalising plans to build on its successes with a major drive to increase access to vaccines and the impact of immunisation programmes by 2020.
 
Undefined

Reduction in HPV in young women in England seen, following national immunization program

Each year around 2,000-2,500 women are diagnosed with cervical cancer in England, the most common cancer in women under 35. Infection with high-risk human papillomavirus (HR HPV) types 16 and 18 is responsible for around 70-80% of cervical cancers. A study conducted by Public Health England and presented today at the Society for General Microbiology's Annual Conference shows a reduction in these two HR HPV types – which are included in the HPV vaccines used – in sexually active young women in England.
 
Undefined

Germs Rule the World: The new germ theory: Infections play a role in many, many diseases—in ways we're just beginning to understand.

In 1882, Robert Koch discovered that a bacterium was behind the world's leading cause of death: tuberculosis (TB). This brilliant combination of investigative logic and savvy microscopy refuted the conventional wisdom that TB was an inherited disease, or some form of cancer. Rather, TB was caused by a particularly wily and insatiable germ. This finding didn’t just accurately identify the agent behind the world’s leading cause of death. It also established an essential new paradigm for medicine.

Undefined

Improving HPV Vaccination Rates in Our Community

Hosted by The Immunization Partnership

From the Immunization Parnership website:

Join The Immunization Partnership and Metro Health for the community forum: Improving HPV Vaccination Rates in our Community.

Speakers will discuss:

Undefined

Immunize Canada announces the new ImmunizeCA App

Visit Immunize Canada about the ImmunizeCA appFrom Immunize Canada's website:

ImmunizeCA App

What it does

Provide Canadians with the ability to:

Undefined

Pages